hHER2/EMT6
CBPG0027
詢 價
留 言
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. Background | |||
| HER2 基因?qū)儆谌吮砥どL因子受體家族之一（ErbB 家族），該家族由 EGFR、HER2、 HER3 和 HER4 四個高度同源的蛋白成員組成，控制著細(xì)胞生長、存活分化和遷移。與其 他三個成員不同的是，HER2 蛋白在本質(zhì)上是一個孤兒受體，缺乏特異性配體，是唯一 一 個可以與家族其他成員結(jié)合形成二聚體結(jié)構(gòu)的受體。HER2 蛋白在與細(xì)胞外配體結(jié)合后， 受體二聚形成異二聚體，隨后自身磷酸化，進(jìn)而激活細(xì)胞內(nèi)信號通路，如絲裂原活化蛋白 激酶/ERK 通路、磷脂酰肌醇 3 激酶/Akt/mTOR 通路等，下游信號通路的激活可調(diào)節(jié)細(xì)胞增 殖、生存、以及腫瘤細(xì)胞的轉(zhuǎn)移等。HER2 在正常情況下表達(dá)低或不表達(dá)，但在各種實體 瘤中經(jīng)常過表達(dá)，HER2 與多種癌癥相關(guān)，包括乳腺癌、胃癌、結(jié)腸癌、膀胱癌、卵巢癌、 子宮內(nèi)膜癌、肺癌等。 | |||
| II. Introduction | |||
| Host Cell: | EMT6 | ||
| Expressed gene: | HER2 | ||
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) | ||
| Freeze Medium: | 90% FBS+10% DMSO | ||
| Culture Medium: | RPMI-1640+10%FBS+2 μg/ml Puromycin | ||
| Mycoplasma Testing: | Negative | ||
| Storage: | Liquid nitrogen | ||
| III. Description of Host Cell Line | |||
| Organism: | Mus musculus, mouse | ||
| Tissue: | breast | ||
| Morphology: | Epithelial | ||
| Growth Properties: | Adherent | ||
| IV. Representative Data | ||||||||||||
|
Figure 1. Recombinant hHER2/EMT6 stably expressing ERBB2. |
||||||||||||
| V. In VIVO Data Data of Experiment 1：
1. Weight Change  Figure 2. Overall effects of different treatments on mouse body weight changes. 2. Tumor Size  Figure 3. Changes in tumor volume over time in mice from different treatment groups. Data of Experiment 2： |
||||||||||||
|
Index |
Content |
|
Animal |
BALB/C, 8weeks, female |
|
Implanted Position |
Subcutaneous (right lower flank region ) |
|
Injected Cell Numbers |
5×10^5/0.1ml |
|
Matrix gel |
Without matrix gel |
1. Weight Change
Figure 4. hHER2/EMT6 Mean Body Weight ± SEM.
2. Tumor Size
Figure 5. hHER2/EMT6 Mean Tumor Volume ± SEM .
NOTE：Data for Experiment 2 were provided by Cobioer (cell data) and Truway Bio (in vivo data model).
